The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection.

"Declarations Ethics approval and consent to participateThe rabbit and mice experimental protocol was approved by the Institute Animal Ethics Committee (IAEC), IISER Kolkata. All the animal protocols were conducted following the Committee for Control and Supervision of Experiments on Animals (CCSEA) guidelines, Ministry of Fisheries, Animal Husbandry and Dairying, Government of India. The permit number of the experimental protocols approved by the IAEC was IISERK/IAEC/AP/2020/56 (rabbit) and IISERK/IAEC/AP/2020/64 (mice). Consent for publicationNot applicable. Competing interestsAmirul Mallick is an Associate Editor for Gut Pathogens and was not involved in the peer review of this article. The authors declare no other competing interests Competing interests Amirul Mallick is an Associate Editor for Gut Pathogens and was not involved in the peer review of this article. The authors declare no other competing interests"

"Funding This work is supported by the Department of Biotechnology, Government of India (Grant No. BT/PR/32841/ADV/90/288/2020) and IISER Kolkata Institutional Fund (Academic Research Fund)."